Pastāsti draugiem par šo preci:
The Path from Biomarker Discovery to Regulatory Qualification Federico Goodsaid
Cena
€ 75,49
Pasūtīts no attālās noliktavas
Paredzamā piegāde . gada 21. aug. - . gada 4. sept.
Saņemiet paziņojumus par jauniem Federico Goodsaid izdevumiem
Mūsu klienti saka:
Pievienot savam iMusic vēlmju sarakstam
The Path from Biomarker Discovery to Regulatory Qualification
Federico Goodsaid
Focuses on biomarker qualification, its history and regulatory settings in both the US and abroad. This book provides a look at the next step to developing biomarkers for clinical use and covers overall concepts, challenges, strategies and solutions based on the experiences of regulatory authorities and scientists.
206 pages, Illustrated
| Mediji | Grāmatas Paperback Book (Grāmata ar mīksto vāku un līmēto muguru) |
| Izlaists | 2013. gada 7. augusts |
| ISBN13 | 9780123914965 |
| Izdevēji | Elsevier Science Publishing Co Inc |
| Lapas | 206 |
| Izmēri | 192 × 235 × 10 mm · 408 g |
| Valoda | Angļu |
| Redaktors | Goodsaid, Federico (PhD, Vice President, Strategic Regulatory Intelligence, Vertex Pharmaceuticals, Cambridge, MA) |
| Redaktors | Mattes, William B. (PhD, DABT, Senior Director of COPD Biomarkers Qualification Consortium, COPD Foundation and Founder and Principal, PharmPoint Consulting) |
